Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a molecular pathogenesis

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 8, 2004, Pages 880-884

  Dacic, Sanja ^a,b   Sasatomi, Eizaburo ^a   Swalsky, Patricia A ^a   Kim, Dong Won ^a   Finkelstein, Sydney D ^a   Yousem, Samuel A ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ALLELIC EXCLUSION; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CELL ULTRASTRUCTURE; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 5Q; CHROMOSOME 9P; CHROMOSOME ARM; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRACTIONAL ALLELIC LOSS; GENE LOCATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY LOSS; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; MICROSATELLITE MARKER; PATHOGENESIS; SCLEROSING HEMANGIOMA OF THE LUNG; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ALLELES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 5; ELDER ABUSE; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PULMONARY SCLEROSING HEMANGIOMA;

EID: 3542990871     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer. 1956;9:53-75.
2. Kay S, Still WJ, Borochovitz D. Sclerosing hemangioma of the lung: an endothelial or epithelial neoplasm? Hum Pathol. 1977;8:468-474.
3. Katzenstein AL, Weise DL, Fulling K, Battifora H. So-called sclerosing hemangioma of the lung: evidence for mesothelial origin. Am J Surg Pathol. 1983;7:3-14.
4. Huszar M, Suster S, Herczeg E, Geiger B. Sclerosing hemangioma of the lung: immunohistochemical demonstration of mesenchymal origin using antibodies to tissue-specific intermediate filaments. Cancer. 1986;58:2422-2427.
5. Nagata N, Dairaku M, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung: an epithelial tumor composed of immunohistochemically heterogenous cells. Am J Clin Pathol. 1987;88:552-559.
6. Rodriguez-Soto J, Colby T, Rouse R. A critical examination of the immunophenotype of pulmonary sclerosing hemangioma. Am J Surg Pathol. 2000;24:442-450.
7. Yousem SA, Wick MR, Singh G, et al. So-called sclerosing hemangiomas of lung: an immunohistochemical study supporting a respiratory epithelial origin. Am J Surg Pathol. 1988;582-590.
8. Yano M, Yamakawa Y, Kiriyama M, Hara M, Murase T. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg. 2002;73:981-983.
9. Chan ACL, Chan JKC. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000;24:1531-1536.
10. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24:906-916.
11. Illei PB, Rosai J, Klimstra DS. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung. Arch Pathol Lab Med. 2001;125:1335-1339.
12. Ng WL, Ma L. Is sclerosing hemangioma of lung an alveolar mixed tumor. Pathology. 1983;15:205-211.
13. Spencer H, Nambu S. Sclerosing haemangioma of the lung. Histopathology. 1986;10:477-487.
14. Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y, Esumi H. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol. 1998;152:1065-1069.
15. Holst VA, Finkelstein S, Yousem SA. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. Am J Surg Pathol. 1998;22:1343-1350.
16. Singh G, Katyal SL, Ordonez NG, et al. Type II pneumocytes in pulmonary tumors: implications for histogenesis. Arch Pathol Lab Med. 1984;108:44-48.
17. Cong WM, Bakker A, Swalsky PA, et al. Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathologic study. J Cancer Res Clin Oncol. 2001;127:187-192.
18. Guo Z, Wu F, Asplund A, et al. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous cell carcinoma. Mod Pathol. 2001;14:54-61.
19. Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol. 2002;26:510-516.
20. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science. 1989;244:207-211.
21. Alvarez-Fernandez E, Carretero-Albinana L, Menarguez-Palanca J. Sclerosing hemangioma of the lung: an immunohistochemical study of intermediate filaments and endothelial markers. Arch Pathol Lab Med. 1989;113:121-124.
22. Katzenstein AL, Gmelich JT, Carrington CB. Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol. 1980;4:343-356.
23. Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka T. Sclerosing hemangioma of the lung: immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer. 1985;55:116-123.
24. Sanz-Ortega J, Saez MC, Sierra E, et al. 3p21, 5q21 and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small cell lung cancer, while they are unusual in patients with no evidence of malignancy. J Pathol. 2001;195:429-434.
25. Satoh Y, Tsuchiya E, Weng SY, et al. Pulmonary sclerosing hemangioma of the lung: a type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer. 1989;64:1310-1317.
26. Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, Colby TV. Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med. 2003;127:321-325.
27. Yano M, Yamakawa Y, Kiriyama M, Hara M, Murase T. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg. 2002;73:981-983.
28. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000;60:4894-4906.
29. Cheng JC, Johnston JO. Giant cell tumor of bone: prognosis and treatment of pulmonary metastases. Clin Orthop. 1997;338:205-214.
30. Siebenrock KA, Unni KK, Rock MG. Giant-cell tumor of bone metastasizing to the lungs: a long term follow-up. J Bone Joint Surg Br. 1998;80:43-47.
31. Chen I, Tu H. Pleomorphic adenoma of the parotid gland metastasizing to the cervical lymph node. Otolaryngol Head Neck Surg. 2000;122:455-457.
32. Takeuchi E, Shimizu E, Sano N, Yamaguchi T, Yanagawa H, Sone S. A case of pleomorphic adenoma of the lung with multiple distant metastases: observations on its oncogene and tumor suppressor gene expression. Anticancer Res. 1998;18:2015-2020.
33. Kayser K, Zink S, Schneider T, et al. Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch. 2000;437:284-292.
34. Yilmaz A, Rush DS, Soslow RA. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol. 2002;26:1142-1150.